Archives
- 2018-07
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
-
In rodents Wang et al Wang and Tsirka b Zhu
2019-07-13
In rodents (Wang et al., 2003, Wang and Tsirka, 2005b, Zhu et al., 2012) and humans (Wang et al., 2011), the major forms of cell death after ICH are necrosis and apoptosis.
-
A large fraction of UCEs are transcribed T UCEs
2019-07-12
A large fraction of UCEs are transcribed (T-UCEs) in a tissue specific manner, and are deregulated in several human cancers (Calin et al., 2007, Fabbri et al., 2008, Fassan et al., 2014, Olivieri et al., 2016).
-
The nitrophenols b d were prepared as described in
2019-07-11
The nitrophenols 34b–d were prepared as described in Scheme 3b.
-
Furthermore certain components in the Melanocyte Growth Medi
2019-07-10
Furthermore, certain components in the Melanocyte Growth Medium seem to influence the response to UV radiation [17]: UV-induced effects on tyrosinase activity were less distinct in melanocytes cultured with phorbol 12-myristate 13-acetate [18], which was also an ingredient in our Melanocyte Growth Medium.
-
br Conflict of interest statement br Acknowledgement The stu
2019-07-09
Conflict of interest statement
-
QSAR based on the D structures of ligands
2019-07-08
QSAR based on the 3D structures of ligands plays an important role in the ligand-based drug discovery and design
-
br Other pathways involved in the preventive and therapeutic
2019-07-05
Other pathways involved in the preventive and therapeutic potential of flavonoids in neurodegenerative diseases Rather than the induction of MAPK/ERK pathway
-
The aim of the present study was
2019-07-04
The aim of the present study was to investigate the participation of CRF1 and CRF2 in the alterations of the dorsal and ventral striatal dopamine release and the vertical and horizontal locomotor activity observed in rats following chronic nicotine treatment and consequent acute withdrawal.
-
The first group of tests was intended
2019-07-03
The first group of tests was intended to evaluate the performance of the GUI initialization.
-
Moving forward the new mathematical model opens doors
2019-07-02
Moving forward, the new mathematical model opens doors for understanding the SCF network, where activity of a component is blunted through mutation or altered in expression in diseased states, and during therapeutic intervention.
-
Stiripentol A first step is reconsideration of the term fami
2019-07-01
A first step is reconsideration of the term family planning.
-
Sea una domesticaci n retraducci n simplificaci n o
2019-06-29
Sea una domesticación, retraducción, simplificación o reversión del francés al español del Caribe, lo cierto es que estos traductores se benefician del discurso literario utilizado por Chateaubriand ya que se muestra como un discurso flexible, capaz de aceptar cambios, desvíos y apropiaciones.
-
VX-765 To date over mutations in KCNQ
2019-06-28
To date, over 250 mutations in KCNQ1 have been found to be linked to LQT1 [34] and new LQT1 causing mutations continue to be identified.
-
LQT can have numerous clinical manifestations ranging
2019-06-28
LQT1 can have numerous clinical manifestations, ranging from no symptoms to sudden cardiac death, which reflects the heterogeneity in channel dysfunction. Mutation type, location, and even a patient׳s ethnic background, age, and gender are critical factors that affect the pathophysiology of the disease
-
Current treatment options for paroxysmal
2019-06-28
Current treatment options for paroxysmal supraventricular tachycardias include AV VX-765 blocking agents (verapamil, diltiazem, propranolol, and metoprolol), class IC anti-arrhythmic agents (propafenone and flecainide), and catheter ablation.
14916 records 994/995 page Previous Next First page 上5页 991992993994995